Definium Therapeutics (DFTX) Debt by Year
Definium Therapeutics, Inc. carried $40.6M in long-term debt against $257.8M in cash and equivalents at the end of fiscal year 2025. Long-term debt rose 85.7% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Definium Therapeutics, Inc. has filed alongside them.
Ticker history: MNMD became DFTX (Definium Therapeutics, Inc.) on . Earlier news and filings retain their original names and dates. View MNMD history.
Annual figures, oldest first. Point at a bar to read its period.
DFTX Debt & Cash by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
DFTX Debt & Cash by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $36.7M-9.2% | $36.5M-11.5% | $40.8M+85.0% | $40.6M+85.7% | $40.4M+66.1% | $41.2M+69.9% | $22.0M+55.3% | $21.9M+54.7% | $24.3M+72.8% | $24.3M | $14.2M | $14.1M |
| Cash & Equivalents | $241.2M+1108.2% | $655.3M+1862.3% | $262.5M+216.8% | $257.8M-5.8% | $20.0M-93.2% | $33.4M-86.3% | $82.9M-67.2% | $273.7M+174.6% | $295.3M+150.9% | $243.1M+108.0% | $252.3M+95.0% | $99.7M-29.9% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Definium Therapeutics, Inc. financials
Frequently Asked Questions
Definium Therapeutics, Inc. carried $40.6M in long-term debt against $257.8M in cash and equivalents at the end of fiscal year 2025.
Definium Therapeutics, Inc. (DFTX) long-term debt rose by 85.7% year over year, from $21.9M to $40.6M in fiscal year 2025.
Definium Therapeutics, Inc. (DFTX) reported $36.7M in long-term debt in Q3 2026. This represents a decrease of 9.2% from the same quarter a year earlier.
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Definium Therapeutics, Inc. (DFTX) reported on that line in every period on record.